Does an endogenous methylpyridinium analogue cause Parkinson's disease?
Testa
B
B
Naylor
R
R
Costall
B
B
Jenner
P
P
Marsden
C D
CD
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans; D008745:Methylation; D010300:Parkinson Disease / Q000209:etiology* / Q000378:metabolism; D011725:Pyridines / Q000378:metabolism* / Q000502:physiology
D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine